New medicines from Germany

New active ingredients are invented in laboratories; often several laboratories are involved. A number of medicines developed in recent years contain active ingredients that were largely invented in German laboratories. This is shown in the following map.

Medicines (approved since 2011) with active ingredients largely invented in Germany. Status: April 2023

The map can also be downloaded as a PDF.

Not all of the drugs listed are available in Germany. In each case, the name of the active ingredient, the indication and the year of the first market launch in a country are indicated.

Note: The market launch of vilobelimab in the USA is imminent.